Patient No. | Subset | Percentage of A2AR-expressing cells | ||||
---|---|---|---|---|---|---|
Control (0 h) | Treatment | |||||
Media | PMA/I | |||||
(2 h) | (4 h) | (2 h) | (4 h) | |||
20 | CD4+ | 15.4 | 21.6 | 21.6 | 21.0 | 21.6 |
CD8+ | 10.8 | 10.9 | 5.4 | 10.0 | 14.1 | |
CD8high | 13.7 | 13.4 | 10.0 | 14.0 | 23.0 | |
CD8low | 11.2 | 15.2 | 4.6 | 13.0 | 14.2 | |
19 | CD4+ | 24.1 | 19.8 | 14.2 | 13.1 | 9.7 |
CD8+ | 11.2 | 11.4 | 7.0 | 16.4 | 25.7 | |
CD8high | 16.0 | 14.3 | 9.1 | 15.5 | 26.1 | |
CD8low | 16.6 | 16.6 | 8.0 | 27.0 | 38.6 | |
89 | CD4+ | 25.9 | 11.3 | 14.9 | 25.1 | 11.4 |
CD8+ | 13.7 | 14.4 | 9.0 | 16.1 | 13.9 | |
CD8high | 15.4 | 16.8 | 10.6 | 18.8 | 15.9 | |
CD8low | 14.7 | 8.1 | 3.9 | 9.5 | 7.0 |